The Proteomics Core Facility provides protein identification and characterization services to about one third of all investigators performing diabetes-related research at the University of Massachusetts. The laboratory is a well established self-supporting facility located on the Worcester Foundation Campus of the University. It provides services to investigators not only at UMass but also to many extramural academic institutions and corporations. The laboratory is equipped with the latest instrumentation for protein/peptide mass spectral analysis. These instruments provide precise mass measurements on both intact proteins and peptides derived from proteolytic digests. In addition, these instruments allow for controlled fragmentation of individual peptides to derive further structural information. Since the genomes of many model organisms are completed the sequences of the various expressed protein products (Proteome) are readily available in public databases. Mass spectrometry has become one of the primary methods for identifying and characterizing proteins of biological interest. The method relies on comparing precisely measured mass values derived from proteolytic peptides or their generated fragments with theoretically calculated values obtained from various databases using specific cleavage rules. Many DERC investigators are studying the proteins that are involved in signal transduction pathways {i.e. the mechanism of insulin action) as well as the polypeptide components of larger multisubunit structures (i.e. the ciliary structures of pancreatic islet cells). The Proteomics Core provides DERC investigators with a centralized laboratory that gives them priority services at highly subsidized rates. Importantly, it also provides face to face consultations on data interpretation as well as sample preparation. This speeds up the characterization of proteins, allowing projects to move along at a more rapid pace.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Massachusetts Medical School Worcester
United States
Zip Code
Desai, Paurav B; San Agustin, Jovenal T; Stuck, Michael W et al. (2018) Ift25 is not a cystic kidney disease gene but is required for early steps of kidney development. Mech Dev 151:10-17
Ly, Socheata; Navaroli, Deanna M; Didiot, Marie-Cécile et al. (2017) Visualization of self-delivering hydrophobically modified siRNA cellular internalization. Nucleic Acids Res 45:15-25
Wang, Feng; McCannell, Kurtis N; Boškovi?, Ana et al. (2017) Rlim-Dependent and -Independent Pathways for X Chromosome Inactivation in Female ESCs. Cell Rep 21:3691-3699
Watkin, Levi B; Mishra, Rabinarayan; Gil, Anna et al. (2017) Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol 140:1206-1210
Wyss, Lena; Stadinski, Brian D; King, Carolyn G et al. (2016) Affinity for self antigen selects Treg cells with distinct functional properties. Nat Immunol 17:1093-101
Delong, Thomas; Wiles, Timothy A; Baker, Rocky L et al. (2016) Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351:711-4
LeBlanc, Scott E; Wu, Qiong; Lamba, Pallavi et al. (2016) Promoter-enhancer looping at the PPAR?2 locus during adipogenic differentiation requires the Prmt5 methyltransferase. Nucleic Acids Res 44:5133-47
Wang, Feng; Shin, JongDae; Shea, Jeremy M et al. (2016) Regulation of X-linked gene expression during early mouse development by Rlim. Elife 5:
Kincaid, Eleanor Z; Murata, Shigeo; Tanaka, Keiji et al. (2016) Specialized proteasome subunits have an essential role in the thymic selection of CD8(+) T cells. Nat Immunol 17:938-45
Townsley, E; O'Connor, G; Cosgrove, C et al. (2016) Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells. Clin Exp Immunol 183:419-30

Showing the most recent 10 out of 707 publications